In order to better characterize and optimize a typical capture ELISA system for Lp(a) lipoprotein, we have analysed kinetic details of the reaction. Plate coating with polyclonal antibody, recognition of captured analyte with monoclonal antibody, and detection of monoclonal antibody with alkaline phosphatase-labeled antiglobulin were essentially complete after one hour, probably being driven forward by a relative excess of reagent. However, complete capture of the Lp(a) analyte required about 6 h at low input concentrations. Shorter time periods for capture might therefore result in decreased sensitivity and reproducibility. Deviations from linearity in the assay dose response were associated with incomplete capture of Lp(a) and significant depletion of the monoclonal recognition antibody. With the final reaction conditions described, no significant differences in immunochemical reactivity between samples were found by analysis of dose response slopes. Finally, interferences from plasminogen, −20°C storage, anticoagulants, LDL, haemolysis, and bilirubin were minimal.
KannelWBCastelliWGordonTMcNamaraPM. Serum cholesterol, lipoproteins, and risk of coronary heart disease: The Framingham study. Ann Int Med1971; 74: 1–12.
2.
CastelliWPDoyleJTGordonTHDL cholesterol and other lipids in coronary heart disease: The cooperative lipoprotein phenotyping study. Circulation1977; 55: 767–72.
3.
GordonTCastelliWPHjortlandMCKannelWBDawberTR. High density lipoprotein as a protective factor against coronary heart disease: The Framingham study. Am J Med1977; 62: 707–14.
4.
KannelWBNeatonJDWentworthDOverall and CHD mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am Heart J1986; 112: 825–36.
5.
UtermannG.The mysteries of lipoprotein(a). Science1989; 246: 904–10.
6.
SankkampMFunkeHSchulteHKohlerEAssmannG.Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem1990; 36: 20–3.
7.
SeedMHoppichlerFReaveleyDRelation of serum lipoprotein(a) concentration and apoliprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med1990; 322: 1494–9.
8.
AlbersJJBrunzellJDKnoppRH. Apoprotein measurements and their clinical application. Clin Lab Med1989; 9: 137–52.
9.
DuvicCRSmithGSledgeWEIdentification of mouse monoclonal antibody, LHLP-1, specific for human Lp(a). J Lipid Res1985; 26: 540–8.
10.
GaubatzJWCushingGLMorrisettJD. Quantitation, isolation, and characterization of human lipoprotein(a). Meth Enzymol1986; 129: 167–86.
11.
AbeMMaedaSMakinoKEnzyme-linked immunosorbent assay of lipoprotein(a) in serum and cord blood. Clin Chim Acta1988; 177: 31–40.
12.
GuoHCArmstrongVWLucGCharacterization of five mouse monoclonal antibodies to apolipoprotein(a) from human Lp(a): Evidence for weak plasminogen reactivity. J Lipid Res1989; 30: 23–37.
13.
WongWLEatonDLBerlouiAFendlyBHassPE. A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a). Clin Chem1990; 36: 192–7.
14.
LabeurCMichielsGBuryJUsherDCRosseneuM.Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies. Clin Chem1989; 35: 1380–4.
15.
RainwaterDLManisGS. Immunochemical characterization and quantitation of lipoprotein(a) in baboons. Development of an assay depending on two antigenically distinct proteins. Atherosclerosis1988; 73: 23–31.
16.
FlessGMSnyderMLScanuAM. Enzyme-linked immunoassay for Lp(a). J Lipid Res1989; 30: 651–62.
17.
Vu DacNMezdourHParraHJLucGLuyeyeIFruchartJC. A selective bi-site immunoenzymatic procedure for human Lp(a) lipoprotein quantification using monoclonal antibodies against apo(a) and apoB. J Lipid Res1989; 30: 1437–43.
18.
McLeanJWTomlinsonJEKuangW-JcDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature1987; 330: 132–7.
19.
KaradiIKostnerGMGriesANimpfJRomicsLMalleE.Lipoprotein(a) and plasminogen are immunochemically related. Biochem Biophys Acta1988; 960: 91–7.
20.
FlessGMRolihCAScanuAM. Heterogeneity of human plasma Lp(a). J Biol Chem1984; 259: 11470–8.
21.
HixsonJEBrittenMLManisGSRainwaterDL. Apolipoprotein(a) (Apo(a)) glycoprotein isoforms result from size differences in Apo(a) mRNA in baboons. J Biol Chem1989; 264: 6013–16.
22.
GavishDAzrolanNBreslowJL. Plasma Lp(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. J Clin Res1989; 84: 2021–7.
23.
KoschinskyMLBeisiegelUHenne-BrunsDEatonDLLawnRM. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochem1990; 29: 640–4.
24.
LindahlGGersforfEMenzelHJSeedMHumphriesSUtermannG.Variation in the size of human apolipoprotein(a) is due to a hypervariable region in the gene. Hum Genet1990; 84: 563–7.
25.
GaubatzJWGhanemKIGuevaraJJrNavaMLPatschWMorrisettJD. Polymorphic forms of human apolipoprotein(a): Inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res1990; 31: 603–13.
26.
HudsonLHayFC. Preparation of IgG on protein A-Sepharose. In: HudsonLHayFC, eds. Practical Immunology, 2nd edn.Blackwell Scientific, Boston1980; 222.
27.
SorensonKBrodbeckU.Assessment of coating-efficiency in ELISA plates by direct protein determination. J Immunol Meth1986; 95: 291–3.
28.
FriguetBChaffoteAFDjavadi-OhanianceLGoldbergME. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Meth1985; 77: 305–19.
29.
VollerABidwellDBartlettA.Enzyme-linked immunosorbent assay. In: RoseHRFriedmanH, eds. Manual of Clinical Immunology, 2nd edn.Washington, DC: American Society for Microbiology1980; 359.
30.
DoetschKM. A New “Capture” Immunoassay for Human Lp(a). PhD Dissertation, Louisiana State University Medical Center, USA, December 1989.
31.
RabinerSFGoldfineIDHartASummariaLRobbinsKC. Radioimmunoassay of human plasminogen and plasmin. J Lab Clin Med1969; 74: 265–73.
32.
PesceAJFordDJGaizutisMPollakVE. Binding of protein to polystyrene in solid-phase immunoassays. Biochim Biophys Acta1977; 492: 399–407.
